{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T07:36:08Z","timestamp":1769585768257,"version":"3.49.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T00:00:00Z","timestamp":1571270400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005693","name":"Parent Project Muscular Dystrophy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007911","name":"University of California, San Diego","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007911","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50 AR070604"],"award-info":[{"award-number":["P50 AR070604"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AR049722"],"award-info":[{"award-number":["R01 AR049722"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-12-1-0416"],"award-info":[{"award-number":["W81XWH-12-1-0416"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.omtm.2019.10.005","type":"journal-article","created":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T18:54:02Z","timestamp":1571684042000},"page":"305-319","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["rAAVrh74.MCK.GALGT2 Demonstrates Safety and Widespread Muscle Glycosylation after Intravenous Delivery in C57BL\/6J Mice"],"prefix":"10.1016","volume":"15","author":[{"given":"Deborah A.","family":"Zygmunt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Ashbrook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chelsea","family":"Menke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guohong","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung Hae","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harshan","family":"Pisharath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brad","family":"Bolon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul T.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2019.10.005_bib1","doi-asserted-by":"crossref","first-page":"5616","DOI":"10.1073\/pnas.082613599","article-title":"Overexpression of the cytotoxic T\u00a0cell GalNAc transferase in skeletal muscle inhibits muscular dystrophy in mdx mice","volume":"99","author":"Nguyen","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2019.10.005_bib2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2353\/ajpath.2007.060927","article-title":"Overexpression of the cytotoxic T\u00a0cell (CT) carbohydrate inhibits muscular dystrophy in the dyW mouse model of congenital muscular dystrophy 1A","volume":"171","author":"Xu","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omtm.2019.10.005_bib3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.nmd.2006.12.004","article-title":"Postnatal overexpression of the CT GalNAc transferase inhibits muscular dystrophy in mdx mice without altering muscle growth or neuromuscular development: evidence for a utrophin-independent mechanism","volume":"17","author":"Xu","year":"2007","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.omtm.2019.10.005_bib4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2353\/ajpath.2009.080967","article-title":"Overexpression of Galgt2 reduces dystrophic pathology in the skeletal muscles of alpha sarcoglycan-deficient mice","volume":"175","author":"Xu","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omtm.2019.10.005_bib5","doi-asserted-by":"crossref","first-page":"C476","DOI":"10.1152\/ajpcell.00456.2008","article-title":"Overexpression of Galgt2 in skeletal muscle prevents injury resulting from eccentric contractions in both mdx and wild-type mice","volume":"296","author":"Martin","year":"2009","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.omtm.2019.10.005_bib6","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/mt.2013.244","article-title":"Plasmapheresis eliminates the negative impact of AAV antibodies on microdystrophin gene expression following vascular delivery","volume":"22","author":"Chicoine","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.10.005_bib7","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1016\/j.ajpath.2016.05.021","article-title":"B4GALNT2 (GALGT2) gene therapy reduces skeletal muscle pathology in the FKRP P448L mouse model of limb girdle muscular dystrophy 2I","volume":"186","author":"Thomas","year":"2016","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omtm.2019.10.005_bib8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.omtm.2018.06.002","article-title":"An isolated limb infusion method allows for broad distribution of rAAVrh74.MCK.GALGT2 to leg skeletal muscles in the rhesus macaque","volume":"10","author":"Xu","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2019.10.005_bib9","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ymthe.2019.01.005","article-title":"rAAVrh74.MCK.GALGT2 protects against loss of hemodynamic function in the aging mdx mouse heart","volume":"27","author":"Xu","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.10.005_bib10","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1006\/mcne.1999.0737","article-title":"Distinct structures and functions of related pre- and postsynaptic carbohydrates at the mammalian neuromuscular junction","volume":"13","author":"Martin","year":"1999","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.omtm.2019.10.005_bib11","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0169-328X(02)00551-X","article-title":"Definition of pre- and postsynaptic forms of the CT carbohydrate antigen at the neuromuscular junction: ubiquitous expression of the CT antigens and the CT GalNAc transferase in mouse tissues","volume":"109","author":"Hoyte","year":"2002","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.omtm.2019.10.005_bib12","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1016\/j.ajpath.2015.06.008","article-title":"Deletion of Galgt2 (B4Galnt2) reduces muscle growth in response to acute injury and increases muscle inflammation and pathology in dystrophin-deficient mice","volume":"185","author":"Xu","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omtm.2019.10.005_bib13","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/0896-6273(91)90301-F","article-title":"Dystrophin-related protein is localized to neuromuscular junctions of adult skeletal muscle","volume":"7","author":"Ohlendieck","year":"1991","journal-title":"Neuron"},{"key":"10.1016\/j.omtm.2019.10.005_bib14","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/0896-6273(93)90152-H","article-title":"Developmental regulation of highly active alternatively spliced forms of agrin","volume":"11","author":"Hoch","year":"1993","journal-title":"Neuron"},{"key":"10.1016\/j.omtm.2019.10.005_bib15","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1083\/jcb.139.6.1507","article-title":"Distribution and function of laminins in the neuromuscular system of developing, adult, and mutant mice","volume":"139","author":"Patton","year":"1997","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.omtm.2019.10.005_bib16","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/0012-1606(84)90333-6","article-title":"Development of basal lamina in synaptic and extrasynaptic portions of embryonic rat muscle","volume":"103","author":"Chiu","year":"1984","journal-title":"Dev. Biol."},{"key":"10.1016\/j.omtm.2019.10.005_bib17","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1083\/jcb.200604179","article-title":"Plectin 1f scaffolding at the sarcolemma of dystrophic (mdx) muscle fibers through multiple interactions with beta-dystroglycan","volume":"176","author":"Rezniczek","year":"2007","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.omtm.2019.10.005_bib18","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0896-6273(91)90177-2","article-title":"Structure and expression of a rat agrin","volume":"6","author":"Rupp","year":"1991","journal-title":"Neuron"},{"key":"10.1016\/j.omtm.2019.10.005_bib19","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1006\/dbio.2001.0530","article-title":"Overexpression of the CT GalNAc transferase in skeletal muscle alters myofiber growth, neuromuscular structure, and laminin expression","volume":"242","author":"Xia","year":"2002","journal-title":"Dev. Biol."},{"key":"10.1016\/j.omtm.2019.10.005_bib20","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/mt.2013.246","article-title":"Vascular delivery of rAAVrh74.MCK.GALGT2 to the gastrocnemius muscle of the rhesus macaque stimulates the expression of dystrophin and laminin \u03b12 surrogates","volume":"22","author":"Chicoine","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.10.005_bib21","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","article-title":"Dystrophin: the protein product of the Duchenne muscular dystrophy locus","volume":"51","author":"Hoffman","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2019.10.005_bib22","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0092-8674(87)90504-6","article-title":"Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals","volume":"50","author":"Koenig","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2019.10.005_bib23","doi-asserted-by":"crossref","first-page":"15162","DOI":"10.1016\/S0021-9258(17)36587-0","article-title":"Molecular cloning of a murine N-acetylgalactosamine transferase cDNA that determines expression of the T lymphocyte-specific CT oligosaccharide differentiation antigen","volume":"269","author":"Smith","year":"1994","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtm.2019.10.005_bib24","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1432-1033.1992.tb16925.x","article-title":"Mouse liver cytidine-5\u2032-monophosphate-N-acetylneuraminic acid hydroxylase. Catalytic function and regulation","volume":"206","author":"Shaw","year":"1992","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.omtm.2019.10.005_bib25","doi-asserted-by":"crossref","first-page":"16458","DOI":"10.1074\/jbc.270.27.16458","article-title":"Molecular cloning of cytidine monophospho-N-acetylneuraminic acid hydroxylase. Regulation of species- and tissue-specific expression of N-glycolylneuraminic acid","volume":"270","author":"Kawano","year":"1995","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtm.2019.10.005_bib26","doi-asserted-by":"crossref","first-page":"42ra54","DOI":"10.1126\/scitranslmed.3000692","article-title":"A human-specific deletion in mouse Cmah increases disease severity in the mdx model of Duchenne muscular dystrophy","volume":"2","author":"Chandrasekharan","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2019.10.005_bib27","doi-asserted-by":"crossref","first-page":"11751","DOI":"10.1073\/pnas.95.20.11751","article-title":"A mutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence","volume":"95","author":"Chou","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2019.10.005_bib28","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1042\/bj20021892","volume":"373","author":"Montiel","year":"2003","journal-title":"Biochem. J."},{"issue":"Suppl 2","key":"10.1016\/j.omtm.2019.10.005_bib29","doi-asserted-by":"crossref","first-page":"8939","DOI":"10.1073\/pnas.0914634107","article-title":"Colloquium paper: uniquely human evolution of sialic acid genetics and biology","volume":"107","author":"Varki","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2019.10.005_bib30","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10719-008-9183-z","article-title":"Multiple changes in sialic acid biology during human evolution","volume":"26","author":"Varki","year":"2009","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.omtm.2019.10.005_bib31","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/sj.mt.6300027","article-title":"Design of tissue-specific regulatory cassettes for high-level rAAV-mediated expression in skeletal and cardiac muscle","volume":"15","author":"Salva","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.10.005_bib32","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.bbagen.2013.09.036","article-title":"The expanding roles of the Sd(a)\/Cad carbohydrate antigen and its cognate glycosyltransferase B4GALNT2","volume":"1840","author":"Dall\u2019Olio","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.omtm.2019.10.005_bib33","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1038\/mt.2012.197","article-title":"Patterns of scAAV vector insertion associated with oncogenic events in a mouse model for genotoxicity","volume":"20","author":"Rosas","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.10.005_bib34","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41591-019-0344-3","article-title":"Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy","volume":"25","author":"Nelson","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2019.10.005_bib35","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1089\/hum.2016.113","article-title":"Induction of T-cell infiltration and programmed death ligand 2 expression by adeno-associated virus in rhesus macaque skeletal muscle and modulation by prednisone","volume":"28","author":"Cramer","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2019.10.005_bib36","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1182\/blood-2008-01-131375","article-title":"Silencing of T lymphocytes by antigen-driven programmed death in recombinant adeno-associated virus vector-mediated gene therapy","volume":"113","author":"Velazquez","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2019.10.005_bib37","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1136\/adc.64.7_Spec_No.902","article-title":"High alkaline phosphatase activity and growth in preterm neonates","volume":"64","author":"Lucas","year":"1989","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.omtm.2019.10.005_bib38","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2012-006768","article-title":"Persistently elevated alkaline phosphatase","volume":"2012","author":"Verma","year":"2012","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.omtm.2019.10.005_bib39","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1001\/jama.2018.14283","article-title":"Effect of human recombinant alkaline phosphatase on 7-day creatinine clearance in patients with sepsis-associated acute kidney injury: a randomized clinical trial","volume":"320","author":"Pickkers","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.omtm.2019.10.005_bib40","doi-asserted-by":"crossref","first-page":"15059","DOI":"10.1038\/mtm.2015.59","article-title":"Treatment of hypophosphatasia by muscle-directed expression of bone-targeted alkaline phosphatase via self-complementary AAV8 vector","volume":"3","author":"Nakamura-Takahashi","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2019.10.005_bib41","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1089\/hum.2010.210","article-title":"Rescue of severe infantile hypophosphatasia mice by AAV-mediated sustained expression of soluble alkaline phosphatase","volume":"22","author":"Matsumoto","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2019.10.005_bib42","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/hum.2010.003","article-title":"Adeno-associated virus serotype 6 capsid tyrosine-to-phenylalanine mutations improve gene transfer to skeletal muscle","volume":"21","author":"Qiao","year":"2010","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2019.10.005_bib43","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/sj.gt.3303029","article-title":"Systemic AAV-9 transduction in mice is influenced by animal age but not by the route of administration","volume":"14","author":"Bostick","year":"2007","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2019.10.005_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/imm.12110","article-title":"Anti-Gal: an abundant human natural antibody of multiple pathogeneses and clinical benefits","volume":"140","author":"Galili","year":"2013","journal-title":"Immunology"},{"key":"10.1016\/j.omtm.2019.10.005_bib45","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1128\/JVI.72.3.2224-2232.1998","article-title":"Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus","volume":"72","author":"Xiao","year":"1998","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2019.10.005_bib46","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1089\/10430349950018427","article-title":"Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses","volume":"10","author":"Clark","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2019.10.005_bib47","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.mcn.2009.04.013","article-title":"The synaptic CT carbohydrate modulates binding and expression of extracellular matrix proteins in skeletal muscle: Partial dependence on utrophin","volume":"41","author":"Yoon","year":"2009","journal-title":"Mol. Cell. Neurosci."}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050119301135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050119301135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:23:14Z","timestamp":1762420994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050119301135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":47,"alternative-id":["S2329050119301135"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2019.10.005","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"rAAVrh74.MCK.GALGT2 Demonstrates Safety and Widespread Muscle Glycosylation after Intravenous Delivery in C57BL\/6J Mice","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2019.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors.","name":"copyright","label":"Copyright"}]}}